However, all instructions come via a QR code only
487,488 Long-term follow-up studies from the Epidemiology of Diabetes Interventions and Complications (EDIC) research have confirmed these benefits
After 56 weeks of treatment in EQUIP, body weight reduction from baseline was 10.9%, and 5.1%, with high (15/92 mg), and low (3.75/23 mg), doses of PHEN/TPM, respectively (vs
Told your pain is "in your head." Handed another prescription that treats symptoms but not causes
GLP-1 is an energy sensor that reduces intestinal motility, prolonging the retention of food in the gut, contributing to more efficient absorption of nutrients and better bioavailability (Winkler et al., 2019)
If you've lost less than 5%, options include: Titrating to a higher Zepbound dose Adding a second medication (e.g., metformin, topiramate) Switching to a different GLP-1 or GLP-1/GIP medication Reassessing diet, exercise, and behavioral factors Most patients who switch from Wegovy to Zepbound and titrate to at least 7.5 mg reach the 5% threshold by week 16
